Contact Us

SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D.
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

SEC Filings

Filing date	Form	Description	Filing Group	View
Dec 11, 2009	DEFA14A	Additional proxy soliciting materials - definitive	Proxy Filings	View HTML 0001193125-09-251559.pdf 0001193125-09-251559.rtf 0001193125-09-251559.xls
Dec 11, 2009	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	Registration Statements	View HTML 0001193125-09-251568.pdf 0001193125-09-251568.rtf 0001193125-09-251568.xls
Dec 09, 2009	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001232524-09-000032.pdf 0001232524-09-000032.rtf
Dec 09, 2009	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0001232524-09-000031.pdf 0001232524-09-000031.rtf
Dec 07, 2009	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001232524-09-000030.pdf 0001232524-09-000030.rtf
Dec 03, 2009	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0001193125-09-246486.pdf 0001193125-09-246486.rtf 0001193125-09-246486.xls
Dec 02, 2009	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001232524-09-000026.pdf 0001232524-09-000026.rtf
Dec 02, 2009	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001232524-09-000027.pdf 0001232524-09-000027.rtf
Dec 02, 2009	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001232524-09-000029.pdf 0001232524-09-000029.rtf
Dec 02, 2009	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001232524-09-000028.pdf 0001232524-09-000028.rtf

Data provided by Kaleidoscope.